Introduction
How are genome engineers building a company with new mRNA platforms to develop new therapies for cancers, neurodegenerative disorders, metabolic diseases, and more? Chidiebere Uzodinma Awah, MD, PhD, the CEO and President of UTR Therapeutics Inc. shares his approach to translating cutting-edge science into a successful life science business model.